Delivery Order SPE2DB22D1041-SPE2DB25FUBM9
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $12.5K to AmerisourceBergen Drug Corp for TRIUMEQ 600-50-300 mg tablets (30-count units) on July 25, 2025, with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed-price contract is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. TRIUMEQ is a combination antiretroviral medication used in HIV treatment, reflecting the Defense Logistics Agency Medical Supply...
- The Defense Logistics Agency awarded a delivery order valued at $33,210.45 to AmerisourceBergen Drug Corp for the supply of TRIUMEQ 600-50-300 mg tablets in quantities of 30 units. The contract employs firm fixed pricing and is classified as a non-set-aside competitive award, with an ultimate completion date of August 11, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for TRIUMEQ 600-50-300 mg tablets (30-count units) valued at $6,519.84 under a Firm Fixed Price contract type. The award was made on July 31, 2025, with an ultimate completion date of August 1, 2025, and represents a non-set-aside competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform at its corporate office location and serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency awarded a delivery order valued at $14,373.49 to AmerisourceBergen Drug Corp for TRIUMEQ 600-50-300 mg tablets (30-count unit dose packaging) on August 11, 2025, with completion scheduled for August 12, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award to the pharmaceutical distributor's Corporate Office located in Conshohocken, Pennsylvania. TRIUMEQ is a combination antiretroviral medication used in HIV treatment, reflecting the...
- The Defense Logistics Agency awarded a $11,096.44 firm fixed price delivery order to AmerisourceBergen Drug Corp for TRIUMEQ 600-50-300 mg tablets (30-count units) with a completion date of August 4, 2025. This competitively awarded, non-set-aside contract represents a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement extending through December 2026. The delivery will be performed...
- The Defense Logistics Agency awarded a $6,519.84 delivery order to AmerisourceBergen Drug Corp for TRIUMEQ 600-50-300 mg tablets (30-count units) with an ultimate completion date of July 25, 2025. This is a firm fixed price, non-set-aside contract with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under a larger federal contract vehicle. This award falls under AmerisourceBergen's significant...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of TRIUMEQ 600-50-300 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with a ceiling value of $4,166.96 and an ultimate completion date of August 1, 2025. The contract does not utilize a set-aside designation and will be performed at the vendor's Conshohocken, Pennsylvania location. This delivery order is issued under AmerisourceBergen Drug...
- This delivery order, awarded August 12, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides 30-count supplies of TRIUMEQ 600-50-300 mg tablets with a ceiling value of $55,079.80 under firm fixed-price terms. The award, which carries an ultimate completion date of August 13, 2025, represents a competitive procurement with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency awarded a Delivery Order valued at $7,320.36 to AmerisourceBergen Drug Corp for the supply of TRIUMEQ 600-50-300 mg tablets in quantities of 30 units. This firm fixed price, non-set-aside contract was awarded on July 28, 2025, with an ultimate completion date of July 29, 2025. TRIUMEQ is an HIV treatment medication combining dolutegravir, abacavir, and lamivudine, reflecting the military and veteran healthcare system's need for critical antiretroviral therapies....
- The Defense Logistics Agency awarded a $38,550.86 delivery order to AmerisourceBergen Drug Corp for TRIUMEQ 600-50-300 mg tablets (30-unit packaging) with an ultimate completion date of August 14, 2025. This firm fixed-price contract represents a non-set-aside competitive award, with performance to be executed at the contractor's Conshohocken, Pennsylvania facility. TRIUMEQ is a prescription antiretroviral medication used in HIV treatment, indicating this delivery supports federal healthcare...
- SPE2DB22D1041Indefinite Delivery Contract
- SPE2DB22D1041-SPE2DB25FUBM9Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $11,525.99 to AmerisourceBergen Drug Corp for the supply of TRIUMEQ 600-50-300 mg tablets in quantities of 30s. This is a firm fixed-price, competitively awarded delivery order with an ultimate completion date of August 20, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has been competitively selected to supply pharmaceutical products supporting military and veteran healthcare systems. TRIUMEQ is a combination antiretroviral medication used in HIV treatment, reflecting the company's role in delivering specialized pharmaceutical commodities across multiple therapeutic domains. The company's federal contract portfolio demonstrates consistent capability to meet DLA requirements through open competition, with delivery orders involving firm fixed pricing across a wide range of therapeutic areas including infectious disease treatments, diabetes medications, neurological treatments, and pain management pharmaceuticals.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.5k | 8/19/25 |